Research
Metabolic adaptation
Prior GLP-1 agonist use is not associated with hospital length of stay in critically ill patients.
Clinicians may conclude that prior GLP-1 agonist use does not prolong hospital stays for critically ill patients.
StrongRefutesmedium confidence
The matched GLP-1 agonist and comparison groups showed similar mean hospital length of stay (13.7 ± 21.3 vs. 13.4 ± 18.1 days, mean difference [MD]: 0.38, 95% CI: -2.21 to 3.05, p = .77).
Why this rating
Based on a large cohort study design with propensity matching.
Source
Prior GLP‐1 agonist use is not associated with adverse inpatient critical care outcomes: A propensity‐matched analysis
Albert K. Park et al. · Journal of Hospital Medicine · 2025
cohort · n=15191Cited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →